Ikkei Takashimizu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ikkei Takashimizu has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Katsunori Sasaki
Affiliations Department of Biotechnology and Biomedical Engineering, Institute for Biomedical Sciences, Interdisciplinary Cluster for Cutting Edge Research, Shinshu University Matsumoto, 3-1-1 Asahi, Matsumoto 390–8621, Japan, Department of Histology and Embryology, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto 390–8621, Japan
2 shared publications - Daihachiro Tomotsune
Affiliation Department of Biotechnology and Biomedical Engineering, Institute for Biomedical Sciences, Interdisciplinary Cluster for Cutting Edge Research, Shinshu University Matsumoto, 3-1-1 Asahi, Matsumoto 390–8621, Japan
1 shared publication Hinako Ichikawa
Department of Anatomy and Organ Technology, School of Medicine, Shinshu University, Matsumoto, Japan
1 shared publication- Ken Matsumoto
Nissui Pharmaceutical Co., Ltd., 1075-2 Hokunanmoro, Yuki City, Ibaraki 307-0036, Japan
1 shared publication Kohei Johkura
Department of Anatomy and Organ Technology, School of Medicine, Shinshu University, Matsumoto, Japan
1 shared publicationLi Cui
Department of Anatomy and Organ Technology, School of Medicine, Shinshu University, Matsumoto, Japan
1 shared publication
Latest Publications
- 1 January 2010
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 391 (3) , 1477-1482
Lanford medium induces high quality hepatic lineage cell differentiation directly from mouse embryonic stem cell-derived mesendoderm
- 1 January 2010
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 391 (3) , 1477-1482
Lanford medium induces high quality hepatic lineage cell differentiation directly from mouse embryonic stem cell-derived mesendoderm
- Open Access
- 1 January 2009
- Published by Hindawi Limited in The Scientific World Journal
- Vol. 9, 190-199
Localization of Liv2 as an Immature Hepatocyte Marker in EB Outgrowth
The objective of this study was to establish Liv2, a surface marker of mouse immature hepatocytes (hepatoblasts), as a selection tool for embryonic stem (ES) cell–derived immature hepatocytes by acquiring basic data on Liv2 in normal mouse embryos and by confirming Liv2 expression in mouse ES-derived cells. The estimated molecular weight of Liv2 was 40–45 kDa, and immunoreactivity was definitively detected in the cell membrane of fetal hepatocytes on embryonic day (E) 9.5, declined gradually until E12.5, and subsequently became undetectable. Liv2 was localized on and close to the cell membrane. Embryoid bodies (EB) were formed from mouse ES cells whose undifferentiated state was confirmed with immunostaining of Nanog by the hanging drop method. A few Liv2-positive cells occurred as a cluster in EB outgrowth on day 7, but only some of these were albumin (ALB)-positive on day 13. These cells had the same pattern of immunoreactivity, i.e., localization on the cell membrane, as immature hepatocytes in the developing liver, although there were other types of cells with a different pattern of immunoreactivity that were seen only as a granular pattern in the cytoplasm and without ALB or the neuronal marker nestin. These results suggest that Liv2 may be useful as a surface marker for immature hepatocytes derived from ES cells. This application would allow for the sole selection of immature hepatocytes and provide a useful tool for regenerative medicine.
- 1 January 2009
- Published by Hindawi Limited in The Scientific World Journal
- Vol. 9, 190-199
Open AccessLocalization of Liv2 as an Immature Hepatocyte Marker in EB Outgrowth
The objective of this study was to establish Liv2, a surface marker of mouse immature hepatocytes (hepatoblasts), as a selection tool for embryonic stem (ES) cell–derived immature hepatocytes by acquiring basic data on Liv2 in normal mouse embryos and by confirming Liv2 expression in mouse ES-derived cells. The estimated molecular weight of Liv2 was 40–45 kDa, and immunoreactivity was definitively detected in the cell membrane of fetal hepatocytes on embryonic day (E) 9.5, declined gradually until E12.5, and subsequently became undetectable. Liv2 was localized on and close to the cell membrane. Embryoid bodies (EB) were formed from mouse ES cells whose undifferentiated state was confirmed with immunostaining of Nanog by the hanging drop method. A few Liv2-positive cells occurred as a cluster in EB outgrowth on day 7, but only some of these were albumin (ALB)-positive on day 13. These cells had the same pattern of immunoreactivity, i.e., localization on the cell membrane, as immature hepatocytes in the developing liver, although there were other types of cells with a different pattern of immunoreactivity that were seen only as a granular pattern in the cytoplasm and without ALB or the neuronal marker nestin. These results suggest that Liv2 may be useful as a surface marker for immature hepatocytes derived from ES cells. This application would allow for the sole selection of immature hepatocytes and provide a useful tool for regenerative medicine.